Natera

Natera is a global leader in cell-free DNA testing dedicated to transforming disease management across women’s health, oncology, and organ health. The company provides non-invasive prenatal screening through its Panorama test alongside Signatera, a personalized molecular residual disease assay that detects circulating tumor DNA to monitor cancer recurrence. Through proprietary bioinformatic algorithms, Natera delivers precision genetic insights that empower clinicians to make timely medical decisions.